Literature DB >> 18203685

Antigen-dependent monophasic or recurrent autoimmune uveitis in rats.

Maria Diedrichs-Möhring1, Christiane Hoffmann, Gerhild Wildner.   

Abstract

Experimental autoimmune uveitis (EAU) in the Lewis rat has been regarded as an acute and monophasic disease. Uveitis can be induced by immunization with retinal soluble antigen (S-Ag), interphotoreceptor retinoid-binding protein (IRBP) or their peptide derivatives (PDSAg from S-Ag and R14 from IRBP) in CFA as well as by the transfer of activated, antigen-specific T cells. Previously, it has been shown that adoptively transferred, IRBP peptide-specific, but not S-Ag peptide-specific T cells can induce relapsing uveitis in rats. We observed spontaneous recurrences of intra-ocular inflammation even after immunization with R14 in CFA and were able to experimentally re-induce uveitis in rats previously immunized with autoantigen peptide in CFA. The efficiency of re-induction was dependent on the mode of pre-treatment [immunization or adoptive transfer (AT)] as well as on the antigen itself. Primary PDSAg-responses prevented subsequent re-induction of disease much more efficiently than primary R14-mediated EAU. In our model, the suppressive effect of CFA did not play a key role in preventing re-induction or spontaneous relapses. Furthermore, epitope spreading could not be demonstrated as a cause for recurrent inflammation. These data suggest that autoimmune responses with different antigen specificities could underlie similar clinical pictures while being differently regulated, which may help explain the variations in the disease courses in patients and the differential responses to therapeutic modalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18203685     DOI: 10.1093/intimm/dxm148

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

Review 1.  Resolution of uveitis.

Authors:  Gerhild Wildner; Maria Diedrichs-Möhring
Journal:  Semin Immunopathol       Date:  2019-10-07       Impact factor: 9.623

2.  A novel pathogenic RBP-3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis.

Authors:  Joanne Boldison; Tarnjit K Khera; David A Copland; Madeleine L Stimpson; Gemma L Crawford; Andrew D Dick; Lindsay B Nicholson
Journal:  Immunology       Date:  2015-08-11       Impact factor: 7.397

Review 3.  Mesenchymal stromal cells for the treatment of ocular autoimmune diseases.

Authors:  Joo Youn Oh; Ryang Hwa Lee
Journal:  Prog Retin Eye Res       Date:  2021-03-26       Impact factor: 21.198

4.  Grouping annotations on the subcellular layered interactome demonstrates enhanced autophagy activity in a recurrent experimental autoimmune uveitis T cell line.

Authors:  Xiuzhi Jia; Jingbo Li; Dejing Shi; Yu Zhao; Yucui Dong; Huanyu Ju; Jinfeng Yang; Jianhua Sun; Xia Li; Huan Ren
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

5.  SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis).

Authors:  Chang He; Cheng-Rong Yu; Mary J Mattapallil; Lin Sun; Joseph Larkin Iii; Charles E Egwuagu
Journal:  Mediators Inflamm       Date:  2016-09-15       Impact factor: 4.711

Review 6.  Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets.

Authors:  Jeongtae Kim; Jiyoon Chun; Meejung Ahn; Kyungsook Jung; Changjong Moon; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2022-03-31

7.  Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.

Authors:  Ulrike Kaufmann; Maria Diedrichs-Möhring; Gerhild Wildner
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 8.  Molecular Mimicry and Uveitis.

Authors:  Gerhild Wildner; Maria Diedrichs-Möhring
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.